stockrowPerrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.
- Revenue
- −5.24%
- EPS
- −494.6%
- Free cash flow
- +138.5%
- Total debt
- −9.62%
Quarter to September 2026, against a year earlier
Follow PRGO
Alert me
Perrigo Company plc (PRGO) Revenue growth
Perrigo Company plc's revenue growth over the twelve months to 30 September 2026 was −4.47%, down 1.7 percentage points from fiscal 2025 (−2.75%). Over the past ten years it has ranged from −37.7% (fiscal 2015) to 100.6% (fiscal 2016); the current reading is higher than 50% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 5.22% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −2.75% | 3.31 |
| FY2024 | −6.06% | (10.64) |
| FY2023 | 4.58% | (2.98) |
| FY2022 | 7.56% | 6.32 |
| FY2021 | 1.24% | (4.40) |
| FY2020 | 5.64% | 23.85 |
| FY2019 | −18.2% | (13.87) |
| FY2018 | −4.34% | 1.99 |
| FY2017 | −6.33% | (106.95) |
| FY2016 | 100.6% | 138.35 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −5.24% | (2.07) |
| Jun 2026 | −3.17% | 3.99 |
| Mar 2026 | −7.16% | (4.64) |
| Dec 2025 | −2.52% | 1.54 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ALVO Alvotech compare | 364.3% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 245.2% |
| BCRX BioCryst Pharmaceuticals, Inc. compare | 60.3% |
| XERS Xeris Biopharma Holdings, Inc. compare | 38.4% |
| ANIP ANI Pharmaceuticals, Inc. compare | 25.9% |
| PBH Prestige Consumer Healthcare Inc. compare | 5.10% |
| PRGO Perrigo Company plc | −4.47% |
| TRLV Trulieve Cannabis Corp. compare | −9.09% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 5.22% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on PRGO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement